SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

$WAGMI is a community-driven meme token built on the Solana blockchain, designed to bring positivity, unity, and humor into the crypto space. The project encourages community engagement through memes, social interaction, and token-based activities. It leverages Solana’s fast and low-cost infrastructure to allow for smooth on-chain interactions, such as token transfers, community games, and NFT integration. The goal is to foster a fun, inclusive ecosystem where holders feel they are part of a larger movement – "We Are Gonna Make It."

WAGMI

WAGMI is trending as community members express strong conviction and positivity around the project's potential, especially within the $SOL ecosystem. Discussions highlight WAGMI's strong community, resilient price action, and potential for significant growth, with many believing "we're all gonna make it."

Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of drug products to extend healthy lifespan. It focuses on developing two novel therapeutic platforms, MyMD-1 and SUPERA-CBD, which aim to treat the causes of disease rather than just addressing the symptoms. MyMD-1 is a clinical-stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cytokines. SUPERA-CBD is a synthetic derivative of cannabidiol being developed to treat conditions such as epilepsy, chronic pain, depression, as well as neuroinflammatory and neurodegenerative diseases. The company was founded in 1989 and is headquartered in New York, NY.

Q/C Technologies Inc.

QCLS is trending amid discussions of its strategic shift towards quantum computing for cryptocurrency applications, particularly its partnership with LightSolver and potential for energy-efficient blockchain solutions. The community is comparing QCLS to other quantum and crypto stocks, with traders closely monitoring its low float and threshold list status. Speculation around news and potential contracts is also fueling interest.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

RGTI is trending due to increased interest in the quantum computing sector, amplified by news of government contracts and private sales. Community discussions revolve around the company's high valuation relative to current revenue, creating a debate between bullish long-term potential and bearish overvaluation concerns. Recent price action and volume spikes are also contributing to the stock's increased visibility.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble Inc. is trending following the announcement of its partnership with AI search engine Perplexity, aimed at improving video discovery on the platform. Community members are discussing the potential benefits of integrating AI tools and Rumble's ties to the crypto world, with some speculating on the impact of this collaboration and potential future acquisitions. The stock's high short interest is also a hot topic, with some anticipating a potential squeeze.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as the community emphasizes its cultural relevance and unique position within the crypto space, drawing comparisons to Bitcoin but with a focus on community and culture. Active community engagement and a recent token burn are driving interest, with some highlighting its potential in the broader cannabis sector. The community is also sharing links to the project's website, social media, and blockchain explorers.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum ($QBTS) is trending due to a recent surge, with the community discussing its strong balance sheet, real-world applications, and potential for further gains. Bullish sentiment is fueled by news of institutional interest and successful deployments of their quantum solvers. Some are drawing comparisons to the dot-com bubble, while others see $QBTS as a long-term play in the burgeoning quantum computing sector.

A multi-agent AI platform dissecting human nature’s first principles through iterative survival challenges and data-driven insights. Core dev has access to one of the founding partners of Two Sigma Ventures - the VC company of one of the biggest hedge funds in the world. Plans to raise seed round and scale after building organic foundation. Project devs are from academia space and are trying to bridge the gap between crypto and academia.

CortexZero

CortexZero is gaining attention as community members highlight its potential for a breakout, pointing to increased liquidity and strong buying activity. Conversations suggest a groundswell of support from early entrants, with many encouraging others to invest via Phantom Wallet. However, some users are also raising concerns about the token's concentration and low market cap.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is trending as investors discuss positive momentum and a potential short squeeze, with community members pointing to the stock being undervalued. Renewed optimism surrounds upcoming data releases, revenue potential and speculation around a buyout, while some traders monitor options activity for bullish signals. Community members are actively discussing resistance levels and expressing optimism about the stock's long-term potential amid volatility.

Quantum Computing, Inc. engages in developing novel algorithms and solutions utilizing quantum and quantum-inspired computing to solve difficult problems in various industries. It leverages its expertise in finance, computing, security, mathematics, and physics to develop commercial applications for the financial, security, and government sectors. The company was founded on July 25, 2001 and is headquartered in Hoboken, NJ.

Quantum Computing Inc

QUBT is trending amid a surge in quantum computing stocks, with community members discussing the company's potential in quantum-secure solutions. Some are pointing to a closed, oversubscribed private placement as a positive catalyst, while others express skepticism about the company's valuation and revenue. Traders are also weighing the potential impact of upcoming government actions related to quantum technology on the sector.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

AAPL is trending due to a mixed analyst outlook, highlighted by Jefferies downgrading the stock to Underperform while Morgan Stanley raised its price target significantly, sparking debate among investors about the company's valuation and future performance. The community is actively discussing the credibility of these differing analyses and their potential impact on Apple's stock price, while also eyeing potential upside catalysts such as strong iPhone 17 sales and long-term bullish positioning by institutions.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shares of Tuhura Biosciences surged 20.2% in after-hours trading on Monday after the company and Kineta, Inc. said shareholders from both firms approved their proposed merger and all related proposals at special meetings held earlier in the day.The stock closed Monday's regular session slightly lower at $2.53, down 0.8%.The merger will combine Tuhura's clinical-stage immuno-oncology platform, including its Phase 3-ready lead asset IFx-2.0, with Kineta's Vista-blocking antibody KVA12123 and a preclinical CD27-targeted therapy.The merged company aims to address primary and acquired resistance to current cancer immunotherapies.Tuhura stockholders approved key measures, including increasing authorized shares to 200 million and reincorporating the company in Delaware.&nbsp;Kineta stockholders also approved the merger terms at a separate special meeting.The transaction is expected to close soon, subject to the fulfillment or waiver of remaining conditions.&nbsp;Tuhura is planning to initiate a randomized Phase 3 trial of IFx-2.0 in combination with Keytruda (pembrolizumab) as first-line therapy for advanced or metastatic Merkel Cell Carcinoma.Kineta's Vista therapy, KVA12123, had previously entered Phase 1/2 trials for solid tumors but was paused in 2024 amid a corporate restructuring that included job cuts to reduce expenses and preserve cash.On Stocktwits, retail sentiment was ‘bullish’ amid ‘extremely high’ message volume.One user said Tuhura could trade above $10 and reach valuations higher than $15.&nbsp;<stembedurl>https://stocktwits.com/Aburose/message/618740816</stembedurl>Another user noted that the stock had consistently moved higher near the close in recent sessions.<stembedurl>https://stocktwits.com/LifesGood/message/618742837</stembedurl>Tuhura’s stock has declined 38.4% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Illustration depicting tumour infiltrating lymphocyte (TIL) therapy for cancer treatment. During TIL therapy, T-cells (blue) that recognise tumour cells (red) are obtained from a patient. | Image source: Getty Images

Tuhura Biosciences Surges After-Hours As Investors Bet On Kineta Merger, Cancer Drug Pipeline

The merger brings together two biotech firms aiming to tackle immune resistance in cancer, with plans to advance programs targeting Merkel Cell Carcinoma.

Equity

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SHYF, ML, HURA, KANT on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SHYF, ML, HURA, KANT on Behalf of Shareholders SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SHYF, ML, HURA, KANT on Behalf of...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PDCO, ML, HURA, KANT on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PDCO, ML, HURA, KANT on Behalf of Shareholders SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PDCO, ML, HURA, KANT on Behalf of...

SHAREHOLDER ALERT: The MandA Class Action Firm Investigates the Merger of TuHURA Biosciences, Inc. - HURA

SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of TuHURA Biosciences, Inc. - HURA SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of TuHURA Biosciences...

HURA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of TuHURA Biosciences, Inc. Is Fair to Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of TuHURA Biosciences, Inc. (NASDAQ: HURA) and Kineta, Inc. is fair to TuHURA shareholders. Halper Sadeh encourages...

TuHURA Biosciences, Inc. is a clinical-stage immuno-oncology company, which engages in the development of novel technologies to overcome resistance to cancer immunotherapy. The firm’s lead product candidate, IFx2.0, is an innate immune agonist designed to overcome primary resistance to checkpoint inhibitors. The company was founded on May 4, 2023 and is headquartered in Tampa, FL.

TuHURA Biosciences Inc.

0 to 25,000

25,000 to 50,000

50,000 to 75,000

75,000 to 100,000

How many jobs did the U.S. add in September? Vote below + drop your exact prediction in the comments. 
 
*Powered by Polymarket

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	-$0.15	--	--	N/A
Q2 '25	-$0.19	-$0.21	-12.50%	MISSED
Q1 '25	-$0.13	--	--	N/A
Q4 '24	--	-$1.40	--	N/A
Q3 '24	-$8.75	-$1.75	80.00%	BEAT

HURA
TuHURA Biosciences Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q3 '25

Historical Earnings

Latest HURA News

HURA TuHURA Biosciences Inc.